Search results
Author(s):
Harriette Van Spall
,
Tauben Averbuch
Added:
1 year ago
HFA 2024 — Dr Tauben Averbuch and Dr Harriette Van Spall (McMaster University, Hamilton, CA) discuss the findings from the PACT-HF trial. In this analysis of PACT-HF, investigators looked at long term sex-specific clinical outcomes and healthcare resource utilisation following hospitalisation for heart failure at 5 years.Findings shows that clinical outcomes and overall costs were similar between…
View more
Author(s):
Aleksandra Bykova
,
Maria Serova
,
Maria Chashkina
,
et al
Added:
8 months ago
Eva Gerdts
Research Area(s) / Expertise:
Job title: Chief of the Non-invasive Cardiac Imaging Unit
Author
Laura Meems
Job title: Cardiologist
Author
Andrea Russo
Job title: Director, Cardiac Electrophysiology and Arrythmia Service
Author
Edina Cenko
Author
Author(s):
Silvana Di Maio
,
Ritu Thamman
,
Julia Grapsa
Added:
7 months ago
Quality of Life After AVR
Author(s):
Meng He
,
Jinwei Zhang
,
Jianbo Yu
,
et al
Added:
1 month ago
Article
Author(s):
Angela Cozma
,
Violeta Briciu
,
Adela Viviana Sitar-Tăut
,
et al
Added:
2 months ago
Author(s):
Safia Chatur
Added:
4 weeks ago
ESC HF 25 - In a FINEARTS HF post-hoc analysis, the relative and absolute effects of finerenone relative to placebo did not significantly differ across kidney function.We are joined by Dr Safia Chatur (Mass General Cardiology, US) to discuss key findings from the FINEARTS-HF trial. This Phase 3 study evaluated the effect of finerenone versus placebo on cardiovascular death and total heart failure…
View more